Fingolimod (Gilenya) licence extended

The European Commission has approved the extension of the licence for fingolimod to allow people to switch to this drug if treatment with other disease modifying drugs has not been successful. Previously people could only switch to fingolimod if they had been treated with beta interferon. Medical News Today Disease modifying drugs for relapsing remitting MS - A to Z of MS
Source: Multiple Sclerosis Trust - Category: Neurology Source Type: news